reported that treatment with Dara increases MM cell death, especially in the presence of a CD14+/CD16+ monocyte subset, and that the combination of Dara with anti-CD47 increases the killing of MM cells resistant to Dara alone (108). The gene discussed is CD14; the disease is Miyoshi myopathy.